Ma Zhongli, Li Canyu
Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China.
Oncol Lett. 2023 Feb 8;25(3):120. doi: 10.3892/ol.2023.13706. eCollection 2023 Mar.
A vaginal yolk sac tumor (YST) is a rare malignant germ cell tumor for infants and children, and it has been >50 years since the first case was reported. The treatment strategy has changed markedly in the past 50 years, from radical surgical treatment to conservative surgery combined with chemotherapy, and then to combined chemotherapy alone. The present study reports the case of a primary vaginal YST in a 13-month-old girl that was successfully treated by tumor resection combined with chemotherapy. The clinical symptoms, imaging features and treatment characteristics are described in detail, as well as the postoperative treatment. There was no local recurrence or metastasis for the 2 years of follow-up to date. A literature review was also conducted to investigate the clinicopathological features, treatment and prognosis of this tumor. Overall, surgery combined with bleomycin, etoposide and carboplatin combination chemotherapy can be an effective option for vaginal YST.
阴道卵黄囊瘤(YST)是一种罕见的婴幼儿恶性生殖细胞肿瘤,自首例报道以来已有50多年。在过去50年里,治疗策略发生了显著变化,从根治性手术治疗到保守手术联合化疗,再到单纯联合化疗。本研究报告了1例13个月大女童原发性阴道YST,通过肿瘤切除联合化疗成功治疗。详细描述了临床症状、影像学特征、治疗特点以及术后治疗情况。迄今为止,随访2年无局部复发或转移。还进行了文献综述,以研究该肿瘤的临床病理特征、治疗和预后。总体而言,手术联合博来霉素、依托泊苷和顺铂联合化疗可能是阴道YST的有效治疗选择。